BioCentury
ARTICLE | Company News

Bayer sales and marketing update

April 7, 2014 7:00 AM UTC

Bayer launched Jaydess low-dose levonorgestrel-releasing intrauterine system in the U.K. as a long-term contraceptive. The product, which costs £69.22 ($115.15) per device, was approved under the EU...